Genomics BioSci & Tech. Co.,Ltd. (TPE:4195)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
17.85
+0.25 (1.42%)
At close: Jul 9, 2026
Market Cap1.29B -4.0%
Revenue (ttm)738.40M +40.8%
Net Income-55.43M
EPS-0.77
Shares Out 72.45M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume314,963
Open17.65
Previous Close17.60
Day's Range17.05 - 18.20
52-Week Range15.10 - 36.85
Beta-0.10
Analystsn/a
Price Targetn/a
Earnings DateAug 14, 2026

About Genomics BioSci & Tech.

Genomics BioSci & Tech. Co.,Ltd. operates as a genomic company in Taiwan. The company offers sequencing, synthesis, genomic, proteomic, and agency and sales services; clinical testing services, such as reproductive health and cancer testing services; and contract development and manufacturing services. The company was founded in 2001 and is based in New Taipei City, Taiwan. [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2001
Country Taiwan
Stock Exchange Taiwan Stock Exchange
Ticker Symbol 4195
Full Company Profile

Financial Performance

In 2025, Genomics BioSci & Tech.'s revenue was 708.38 million, an increase of 36.86% compared to the previous year's 517.58 million. Losses were -39.43 million, -82.33% less than in 2024.

Financial Statements